- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | May 26, 2020
Distillery Therapeutics
Disrupting mitochondrial DNA-mediated paracrine signaling for prostate cancer
BioCentury | Oct 13, 2017
Product Development
Eyeing complement data
Sorting through complement data in dry AMD
BioCentury | Jul 11, 2017
Emerging Company Profile
Complementary ALS play
Why Alsonex is targeting the complement system at C5a to treat ALS
Items per page:
1 - 10 of 21